Previous close | 6.67 |
Open | 6.65 |
Bid | 2.69 x 900 |
Ask | 10.73 x 1800 |
Day's range | 6.65 - 6.75 |
52-week range | 5.50 - 8.00 |
Volume | |
Avg. volume | 1,666 |
Market cap | 239.778M |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.73 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 14.60 |
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Molecular Partners AG's ( VTX:MOLN ) price-to-sales (or "P/S") ratio of 10.1x might make it look like a sell right now...
Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...
Molecular Partners ( VTX:MOLN ) Full Year 2022 Results Key Financial Results Revenue: CHF189.6m (up by CHF179.8m from...
A look at the shareholders of Molecular Partners AG ( VTX:MOLN ) can tell us which group is most powerful. With 41...
Molecular Partners (VTX:MOLN) has had a great run on the share market with its stock up by a significant 20% over the...
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...